Goethel SF, Marahiel MA (1999) Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol Life Sci 55:423–436
Article
CAS
Google Scholar
Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–547
PubMed
Article
CAS
Google Scholar
Wiederecht G, Lam E, Hung S, Martin M, Sigal N (1993) The mechanism of action of FK-506 and cyclosporin A. Ann NY Acad Sci 696:9–19
Article
Google Scholar
Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC (2000) Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87:789–796
PubMed
CAS
Google Scholar
Sokolskaja E, Luban J (2006) Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr Opin Microbiol 9:404–408
PubMed
Article
CAS
Google Scholar
Konttinen YT, Li TF, Mandelin J, Sorsa T, Santavirta S, Virtanen I (2000) Increased expression of extracellular matrix metalloproteinase induce in rheumatoid synovium. Arthritis Rheum 43:275–280
PubMed
Article
CAS
Google Scholar
Campa MJ, Wang MZ, Howard B, Fitzgerald MC Jr, Patz EF (2003) Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin A as potential molecular targets in non-small cell lung cancer. Cancer Res 63:1652–1656
PubMed
CAS
Google Scholar
Obama K, Kato T, Hasegawa S, Satoh S, Nakamura Y, Furukawa Y (2006) Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin Cancer Res 12:70–76
PubMed
Article
CAS
Google Scholar
Chen S, Zhu B, Yu L (2006) In silico comparison of gene expression levels in ten human tumor types reveals candidate genes associated with carcinogenesis. Cytogenet Genome Res 112:53–59
PubMed
Article
CAS
Google Scholar
Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P, Kerr DJ (2001) Hepatocellular carcinoma. Ann Oncol 12:161–172
PubMed
Article
CAS
Google Scholar
Tang ZY (2001) Hepatocellular carcinoma—cause, treatment and metastasis. World J Gastroenterol 7:445–454
PubMed
CAS
Google Scholar
Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139–146
PubMed
Article
CAS
Google Scholar
Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer—trials and tribulations. Science 295:2387–2392
PubMed
Article
CAS
Google Scholar
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630–636
PubMed
CAS
Google Scholar
Chen S, Zhang MJ, Ma HH, Saiyin H, Shen SQ, Xi JJ, Wan B, Yu L (2008) Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol 61:459–469
PubMed
Article
CAS
Google Scholar
Liu LH, Li CZ, Cai C, Xiang JB, Cao ZG (2010) Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis. Biochem Biophys Res Commun 391:1000–1006
PubMed
Article
CAS
Google Scholar
Yang Y, Lu N, Zhou J, Chen Z, Zhu P (2008) Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology 47:1299–1310
PubMed
Article
CAS
Google Scholar
Seizera P, Schobergera T, Schota M, Langa MR, Langera HF, Bigalkea B, Kraera BF, Borsta O, Dauba K, Heidenreichb O, Schmidtc R, Lindemanna S, Herouyd Y, Gawaza M, Maya AE (2010) EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 209:51–57
Article
Google Scholar
Hofmann UB, Houben R, Bröcker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87:307–314
PubMed
Article
CAS
Google Scholar
Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353:1253–1257
PubMed
Article
CAS
Google Scholar
Liotta LA, Stetler-Stevenson WG, Steeg PS (1991) Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9:543–551
PubMed
Article
CAS
Google Scholar
Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buchwalder LF, Murk W, Funai EF, Schatz F (2008) Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod 78:1064–1072
PubMed
Article
CAS
Google Scholar
Morris-Wiman J, Burch H, Basco E (2000) Temporospatial distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases during murine secondary palate morphogenesis. Anat Embryol 202:129–141
PubMed
Article
CAS
Google Scholar
Brown NL, Yarram SJ, Mansell JP, Sandy JR (2002) Matrix metalloproteinases have a role in palatogenesis. J Dent Res 81:826–830
PubMed
Article
CAS
Google Scholar
Yurchenko V, Zybarth G, O’Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P, Sherry B, Bukrinsky M (2002) Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 277:22959–22965
PubMed
Article
CAS
Google Scholar
Chen X, Lin J, Takuro K, Su J, Lin W, Xie HF, Wu YX, Li J, Chen ML, Chang J (2006) A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 66:11323–11330
PubMed
Article
CAS
Google Scholar
Tomita T, Nakase T, Kaneko M, Shi K, Takahi K, Ochi T, Yoshikawa H (2002) Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 46:373–378
PubMed
Article
CAS
Google Scholar